RNA Research
Study results from Alnylam Pharmaceuticals, Inc. provide new insights into RNA research
Published in Gene Therapy Weekly, November 9th, 2006
Fresh data on rna research are presented in the report "Therapeutic potential of RNA interference for neurological disorders. During the past decade, numerous molecular mediators of neurodegenerative diseases and neurological disorders have been identified and validated, yet few novel therapies have emerged and the unmet medical needs remain high. These molecular mediators belong to target classes such as ion channels, neurotransmitters and neurotransmitter receptors, cytokines, growth factors, enzymes and other proteins," scientists in the United States report.
"In some cases, substantial pre-clinical validation exists, but the molecular target has not been readily...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-11-09)
More Articles from Gene Therapy Weekly
- Cholangiocarcinoma
Cholangiocarcinoma cell growth inhibited by receptor ligand - Genetics & Genomics
MicroRNA expression detected by RNA oligonucleotide hybridization - Genetics & Genomics
Therapeutic exon skipping achieved in Duchenne muscular dystrophy - RNA Interference
RNA interference-mediated enzyme silencing achieves therapeutic benefit - Vector Development
Lentiviral vector may be used to study and treat proliferative diseases - Cancer Gene Therapy
Reports outline cancer gene therapy research from West Virginia University, Mary Babb Randolph Cancer Center - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
